Potency data for probe BAY-826 and control BAY-309
In vitro potency
| Target name | Target information | Species | Assay description | BAY-826 | BAY-309 | Publication of assay conditions |
|---|---|---|---|---|---|---|
| TEK | Bacterial; Partial (N804/T1112) | Homo sapiens | KINOMEScan (DiscoveRx Corp) with TEK | Kd = 1.6 nM | PMID: 27787897 | |
| TIE1 | Bacterial; Partial (T819/A1138) | Homo sapiens | KINOMEScan (DiscoveRx Corp) with TIE1 | Kd = 0.9 nM | PMID: 27787897 | |
| DDR1 | Bacterial; Partial (R565/V876) | Homo sapiens | KINOMEScan (DiscoveRx Corp) with DDR1 | Kd = 0.4 nM | PMID: 27787897 | |
| DDR2 | Mammalian; Partial (V555/E855) | Homo sapiens | KINOMEScan (DiscoveRx Corp) with DDR2 | Kd = 1.3 nM | PMID: 27787897 | |
| STK10 | Bacterial; Partial (E16/V314) | Homo sapiens | KINOMEScan (DiscoveRx Corp) with STK10 | Kd = 5.9 nM | PMID: 27787897 | |
| TEK | Homo sapiens | Bayer in-house kinase assay with TEK | IC50 = 0.45 nM | |||
| KDR | Mammalian; Partial (R787/P1253) | Homo sapiens | KINOMEScan (DiscoveRx Corp) with KDR | Kd = 1.6 µM | ||
| FGFR1 | Homo sapiens | Bayer in-house kinase assay with FGFR1 | IC50 > 10 µM | |||
| PDGFRB | Homo sapiens | Bayer in-house kinase assay with PDGFRB | IC50 > 20 µM | |||
| FLT4 | Homo sapiens | Bayer in-house kinase assay with FLT4 | IC50 = 0.44 µM | |||
| FGFR3 | Homo sapiens | Bayer in-house kinase assay with FGER3 | IC50 > 10 µM | |||
| TEK | Bacterial; Partial (N804/T1112) | Homo sapiens | KINOMEScan (DiscoveRx Corp) with TEK | Kd > 20 µM |
In cell potency
| Target name | Target information | Species | Assay description | BAY-826 | BAY-309 | Publication of assay conditions |
|---|---|---|---|---|---|---|
| TEK | Homo sapiens | Cellular mechanistic assay: inhibition of TEK autophosphorylation in human umbilical vein endothelial cells (HUVEC), pTEK-ELISA | EC50 = 1.3 nM | PMID: 27787897 | ||
| TEK | Homo sapiens | NanoBRET assay (SGC Frankfurt) with TEK | EC50 = 1.7 nM ± 0.230 nM (n=3) | |||
| TIE1 | Homo sapiens | NanoBRET assay (SGC Frankfurt) with TIE1 | EC50 = 11 nM ± 5.600 nM (n=3) | |||
| DDR1 | Homo sapiens | NanoBRET assay (SGC Frankfurt) with DDR1 | EC50 = 1.5 nM ± 0.220 nM (n=3) | |||
| DDR2 | Homo sapiens | NanoBRET assay (SGC Frankfurt) with DDR2 | EC50 = 0.54 nM ± 0.047 nM (n=3) | |||
| STK10 | Homo sapiens | NanoBRET assay (SGC Frankfurt) with STK10 | EC50 = 110 nM ± 2.100 nM (n=3) | |||
| EPHB6 | Homo sapiens | NanoBRET assay (SGC Frankfurt) with EPHB6 | EC50 = 12 µM ± 0.970 µM (n=3) | |||
| LYN | Homo sapiens | NanoBRET assay (SGC Frankfurt) with LYN | EC50 = 7.4 µM ± 0.450 µM (n=3) | |||
| TEK | Homo sapiens | NanoBRET assay (SGC Frankfurt) with TEK | EC50 = 3.3 µM ± 0.340 µM (n=3) | |||
| TIE1 | Homo sapiens | NanoBRET assay (SGC Frankfurt) with TIE1 | EC50 = 2.6 µM ± 0.550 µM (n=3) | |||
| DDR1 | Homo sapiens | NanoBRET assay (SGC Frankfurt) with DDR1 | EC50 = 200 nM ± 32.000 nM (n=3) | |||
| DDR2 | Homo sapiens | NanoBRET assay (SGC Frankfurt) with DDR2 | EC50 = 2.7 µM ± 1.200 µM (n=3) | |||
| STK10 | Homo sapiens | NanoBRET assay (SGC Frankfurt) with STK10 | EC50 = 3.2 µM ± 0.440 µM (n=3) | |||
| EPHB6 | Homo sapiens | NanoBRET assay (SGC Frankfurt) with EPHB6 | EC50 = 27 µM ± 5.800 µM (n=3) | |||
| LYN | Homo sapiens | NanoBRET assay (SGC Frankfurt) with LYN | EC50 > 50 µM (n=3) |